Browse by all authors Browse By Author Name - McLachlan,+AJ

Browse Results (11 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1993) Absorption and In-Vivo Dissolution of Hydroxycholoroquine in Fed Subjects Assessed Using Deconvolution Techniques. British Journal of Clinical Pharmacology, 36 5: 405-411. 29   8
McLachlan, AJ, Gross, AS, Beal, JL, Minns, I and Tett, SE (2001) Analytical validation for a series of marker compounds used to assess renal drug elimination processes. Therapeutic Drug Monitoring, 23 1: 39-46. 64   11
Roberts, AW, He, S, Bradstock, KF, Hertzberg, MS, Durrant, STS, Ritchie, D, Lewis, ID, Marlton, P, McLachlan, AJ, Yeadon, TM, Busfield, SJ, Barriden, MJ, Davis, R, Hosback, S, Mirosa, D, Biondo, M, Bamford, S, DeWitte, M and Basser, R (2008). A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML. In: , Blood. 50th Annual Meeting of the American- Society-of-Hematology, San Francisco Ca, (1015-1016). Dec 06-09, 2008. 82   1
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1994) Bioavailability of Hydroxychloroquine Tablets in Patients with Rheumatoid-Arthritis. British Journal of Rheumatology, 33 3: 235-239. 12   12
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1994). Disposition and Absorption of Hydroxychloroquine Enantiomers Following a Single-Dose of the Racemate. In: , Chirality. 4th International Symposium on Chiral Discrimination, Montreal Canada, (360-364). Sep 19-22, 1993. 8   10
McLachlan, AJ, Tett, SE, Cutler, DJ and Day, RO (1993) Disposition of the Enantiomers of Hydroxychloroquine in Patients with Rheumatoid-Arthritis Following Multiple Doses of the Racemate. British Journal of Clinical Pharmacology, 36 1: 78-81. 8   22
McLachlan, AJ, Tett, SE and Cutler, DJ (1991) High-Performance Liquid-Chromatographic Separation of the Enantiomers of Hydroxychloroquine and its Major Metabolites in Biological-Fluids Using An Alpha-1-Acid Glycoprotein Stationary Phase. Journal of Chromatography-Biomedical Applications, 570 1: 119-127. 6   30
Tett, SE, McLachlan, AJ, Cutler, DJ and Day, RO (1994). Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine Enantiomers in Patients with Rheumatoid-Arthritis Receiving Multiple Doses of Racemate. In: , Chirality. 4th International Symposium on Chiral Discrimination, Montreal Canada, (355-359). Sep 19-22, 1993. 14   11
McLachlan, AJ and Tett, SE (1996) Pharmacokinetics of fluconazole in people with HIV infection: A population analysis. British Journal of Clinical Pharmacology, 41 4: 291-298. 2   27
McLachlan, AJ, Cutler, DJ and Tett, SE (1993) Plasma-Protein Binding of the Enantiomers of Hydroxychloroquine and Metabolites. European Journal of Clinical Pharmacology, 44 5: 481-484. 2   13
Gross, AS, McLachlan, AJ, Minns, I, Beal, JB and Tett, SE (2001) Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol. British Journal of Clinical Pharmacology, 51 6: 547-555. 322   9